EE05175B1 - Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis - Google Patents

Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis

Info

Publication number
EE05175B1
EE05175B1 EEP200200204A EEP200200204A EE05175B1 EE 05175 B1 EE05175 B1 EE 05175B1 EE P200200204 A EEP200200204 A EE P200200204A EE P200200204 A EEP200200204 A EE P200200204A EE 05175 B1 EE05175 B1 EE 05175B1
Authority
EE
Estonia
Prior art keywords
preparation
medicine
substituted benzimidazole
substituted
benzimidazole preparation
Prior art date
Application number
EEP200200204A
Other languages
English (en)
Estonian (et)
Inventor
Br�lls Mikael
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200204A publication Critical patent/EE200200204A/xx
Publication of EE05175B1 publication Critical patent/EE05175B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200200204A 1999-10-22 2000-10-13 Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis EE05175B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles
PCT/SE2000/001992 WO2001028558A1 (en) 1999-10-22 2000-10-13 Formulation of substituted benzimidazoles

Publications (2)

Publication Number Publication Date
EE200200204A EE200200204A (et) 2003-04-15
EE05175B1 true EE05175B1 (et) 2009-06-15

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200204A EE05175B1 (et) 1999-10-22 2000-10-13 Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis

Country Status (36)

Country Link
US (1) US6730685B1 (xx)
EP (1) EP1274427B1 (xx)
JP (1) JP2003512327A (xx)
KR (1) KR100785603B1 (xx)
CN (1) CN1213751C (xx)
AR (1) AR029005A1 (xx)
AT (1) ATE304851T1 (xx)
AU (1) AU782866B2 (xx)
BG (1) BG65580B1 (xx)
BR (1) BR0014895A (xx)
CA (1) CA2425199C (xx)
CO (1) CO5261533A1 (xx)
CY (1) CY1106055T1 (xx)
CZ (1) CZ20021375A3 (xx)
DE (1) DE60022789T2 (xx)
DK (1) DK1274427T3 (xx)
EE (1) EE05175B1 (xx)
ES (1) ES2246903T3 (xx)
HK (1) HK1051142A1 (xx)
HU (1) HUP0203121A3 (xx)
IL (2) IL149107A0 (xx)
IS (1) IS2196B (xx)
MX (1) MXPA02003900A (xx)
MY (1) MY131971A (xx)
NO (1) NO329545B1 (xx)
NZ (1) NZ518155A (xx)
PL (1) PL199868B1 (xx)
RU (1) RU2286782C2 (xx)
SE (1) SE9903831D0 (xx)
SI (1) SI1274427T1 (xx)
SK (1) SK286266B6 (xx)
TR (1) TR200201103T2 (xx)
TW (1) TWI236372B (xx)
UA (1) UA74347C2 (xx)
WO (1) WO2001028558A1 (xx)
ZA (1) ZA200202905B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5412023B2 (ja) * 2000-08-04 2014-02-12 武田薬品工業株式会社 ベンズイミダゾール化合物の塩およびその用途
CA2419067C (en) * 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
CN100558726C (zh) * 2003-02-24 2009-11-11 田边三菱制药株式会社 泰妥拉唑的对映体及其在治疗中的应用
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
CN101442985A (zh) * 2006-05-09 2009-05-27 阿斯利康(瑞典)有限公司 在其最终容器中被电离辐射灭菌了的包含质子泵抑制剂的肠胃外制剂
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
CN107109464B (zh) 2014-11-13 2021-03-30 3M创新有限公司 用于检测样品中细菌atp的包含atp-二磷酸水解酶的试剂盒
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
DK399389A (da) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
AU674015B2 (en) 1992-07-28 1996-12-05 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
WO1999036060A1 (en) * 1998-01-20 1999-07-22 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
KR100785603B1 (ko) 2007-12-14
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
EP1274427B1 (en) 2005-09-21
PL199868B1 (pl) 2008-11-28
WO2001028558A1 (en) 2001-04-26
CO5261533A1 (es) 2003-03-31
EE200200204A (et) 2003-04-15
ZA200202905B (en) 2003-07-14
NZ518155A (en) 2004-07-30
HUP0203121A2 (hu) 2003-01-28
CN1213751C (zh) 2005-08-10
HK1051142A1 (en) 2003-07-25
KR20020059637A (ko) 2002-07-13
CY1106055T1 (el) 2011-04-06
CN1382048A (zh) 2002-11-27
IL149107A (en) 2008-04-13
EP1274427A1 (en) 2003-01-15
DK1274427T3 (da) 2005-12-27
SI1274427T1 (sl) 2006-02-28
IS2196B (is) 2007-01-15
SK286266B6 (sk) 2008-06-06
IL149107A0 (en) 2002-11-10
BR0014895A (pt) 2002-06-18
MY131971A (en) 2007-09-28
JP2003512327A (ja) 2003-04-02
SE9903831D0 (sv) 1999-10-22
UA74347C2 (uk) 2005-12-15
SK5392002A3 (en) 2002-10-08
AU782866B2 (en) 2005-09-01
BG106602A (en) 2002-12-29
TWI236372B (en) 2005-07-21
PL354926A1 (en) 2004-03-22
CZ20021375A3 (cs) 2002-09-11
MXPA02003900A (es) 2002-09-30
AU1182301A (en) 2001-04-30
CA2425199A1 (en) 2001-04-26
NO20021860D0 (no) 2002-04-19
TR200201103T2 (tr) 2002-08-21
ES2246903T3 (es) 2006-03-01
US6730685B1 (en) 2004-05-04
CA2425199C (en) 2010-12-07
NO329545B1 (no) 2010-11-08
RU2286782C2 (ru) 2006-11-10
BG65580B1 (bg) 2009-01-30
ATE304851T1 (de) 2005-10-15
AR029005A1 (es) 2003-06-04
NO20021860L (no) 2002-05-21
IS6347A (is) 2002-04-17
HUP0203121A3 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
EE200300236A (et) 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE200300581A (et) Karboksamiid-asendatud fenüüluurea derivaadid ja nende kasutamine, ravim ja selle valmistamismeetod
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04565B1 (et) Adamantaani derivaadid, nende saamine ja kasutamine
EE05109B1 (et) Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
EE200300048A (et) Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
EE04236B1 (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
EE200000723A (et) Asendatud indolinoonid, nende valmistamine ja nende kasutamine ravimitena
EE200100568A (et) 6-alkenüül-, 6-alkünüül- ja 6-epoksüepotilooni derivaadid, nende valmistamismeetod ja kasutamine farmatseutilistes preparaatides
EE05214B1 (et) Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE200200197A (et) 6-asendis asendatud indolinoonid, nende valmistamine ja nende kasutamine ravimitena
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE05175B1 (et) Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis
EE04344B1 (et) Telmisartaani polümorfid, meetodid nende valmistamiseks ja nende kasutamine ravimi valmistamiseks
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
EE200100391A (et) Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE200000596A (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
EE200400028A (et) Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20121013